1.Effects of chronotherapy of benazepril on the diurnal profile of RAAS and clock genes in the kidney of 5/6 nephrectomy rats.
Xiao-mei HUANG ; Jing-ping YUAN ; Xing-ruo ZENG ; Cai-xia PENG ; Qi-hui MEI ; Wen-li CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(3):368-374
This study investigated the effects of benazepril administered in the morning or evening on the diurnal variation of renin-angiotensin-aldosterone system (RAAS) and clock genes in the kidney. The male Wistar rat models of 5/6 subtotal nephrectomy (STNx) were established. Animals were randomly divided into 4 groups: sham STNx group (control), STNx group, morning benazepril group (MB) and evening benazepril group (EB). Benazepril was intragastrically administered at a dose of 10 mg/kg/day at 07:00 and 19:00 in the MB group and EB group respectively for 12 weeks. All the animals were synchronized to the light:dark cycle of 12:12 for 12 weeks. Systolic blood pressure (SBP), 24-h urinary protein excretion and renal function were measured at 11 weeks. Blood samples and kidneys were collected every 4 h throughout a day to detect the expression pattern of renin activity (RA), angiotensin II (AngII) and aldosterone (Ald) by radioimmunoassay (RIA) and the mRNA expression profile of clock genes (bmal1, dbp and per2) by real-time PCR at 12 weeks. Our results showed that no significant differences were noted in the SBP, 24-h urine protein excretion and renal function between the MB and EB groups. There were no significant differences in average Ald and RA content of a day between the MB group and EB group. The expression peak of bmal1 mRNA was phase-delayed by 4 to 8 h, and the diurnal variation of per2 and dbp mRNA diminished in the MB and EB groups compared with the control and STNx groups. It was concluded when the similar SBP reduction, RAAS inhibition and clock gene profile were achieved with optimal dose of benazepril, morning versus evening dosing of benazepril has the same renoprotection effects.
Animals
;
Antihypertensive Agents
;
administration & dosage
;
Benzazepines
;
administration & dosage
;
CLOCK Proteins
;
metabolism
;
Circadian Rhythm
;
Drug Chronotherapy
;
Gene Expression Profiling
;
Hypertension, Renal
;
drug therapy
;
physiopathology
;
Kidney
;
drug effects
;
physiopathology
;
surgery
;
Male
;
Nephrectomy
;
Rats
;
Rats, Wistar
;
Renin-Angiotensin System
;
drug effects
;
Treatment Outcome
2.Simultaneous determination of 4 phenolic acids in cangerzi by ultra-performance liquid chromatography.
Liu YANG ; Zhi-jun SU ; Shun-jun XU ; Jin-xiong WU ; Lu-lu CHEN ; Ruo-long ZHOU ; Xiong LI ; Xing ZENG
Acta Pharmaceutica Sinica 2010;45(12):1537-1540
In this study, an analytical method was developed and used to quantify simultaneously protocatechuic acid, neochlorogenic acid, cryptochlorogenic acid and 1, 3-dicaffeoylquinic acid--four bioactive compounds contained in Fructus Xanthii using UPLC. The contents of four phenolic components of 28 batches of samples collected from different product areas and markets were determined and compared by means of this established method. The mobile phase was composed of methanol and water containing 0.1% phosphoric acid. Chromatography was monitored at dual-wavelengths--220 and 327 nm. Flow rate was 0.4 mL x min(-1) and column temperature was 35 degrees C. The correlation coefficient between concentration and chromatographic peak area of protocatechuic acid, neochlorogenic acid, cryptochlorogenic acid and 1, 3-dicaffeoylquinic acid was over 0.9999 in the range of 0.3570-35.70, 2.500-250.0, 1.060-106.1, 1.010-101.0 microg x mL(-1), respectively. The average recoveries of the four compounds were 97.68%, 99.55%, 97.92% and 100.4%, respectively. In conclusion, the established method can rapidly attain an accurate and reproducible result used to control the quality of Fructus Xanthii.
Chlorogenic Acid
;
analysis
;
Chromatography, High Pressure Liquid
;
Drugs, Chinese Herbal
;
analysis
;
Fruit
;
chemistry
;
Hydroxybenzoates
;
analysis
;
Plants, Medicinal
;
chemistry
;
Quality Control
;
Quinic Acid
;
analogs & derivatives
;
analysis
;
Reproducibility of Results
;
Xanthium
;
chemistry
3.n-butanol part from Qubai tablet and study on its pharmacodynamics to de melanocyte model
Songleng DUAN ; Hongyan GU ; Honglei NIAN ; Ruo XING ; Weixin ZENG
China Pharmacy 2022;33(9):1049-1055
OBJECTIVE To stud y the chemical cons tituents of n-butanol part of Qubai tablet and its pharmacodynamic effect on the model of de melanocyte. METHODS The n-butanol part of Qubai tablet was prepared. The chemical constituents were analyzed by ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS). Taking mice B 16 melanoma cells as the research object ,the de melanocyte model was established and divided into model group ,positive control different concentration groups(8-methoxypsoralen 10,50,100,150,200 μmol/L),solvent group (diluted with DMSO )and Qubai tablet n-butanol part different concentration groups (10,50,100,150,200 μmol/L). The number of cells were observed by inverted microscope ,and the cell proliferation rate ,the rate of melanin production and promotion rate of tyrosinase activity were also detected. RESULTS In the positive and negative ion mode ,53 compounds in the n-butanol part of Qubai tablet were preliminarily determined (29 in the positive ion mode ,33 in the negative ion mode ,overlapping 9),of which coumarins accounted for the largest proportion , followed by flavonoids. The n-butanol part of Qubai tablet could significantly increase the number of cells ,which was positively correlated with the action time and administration concentration. It could significantly increase the proliferation rate of cells ,the rate of melanin production and promotion rate of tyrosinase activity (P<0.01). CONCLUSIONS Coumarins and flavonoids may be the material basis for the anti-vitiligo effect of n-butanol part from Qubai tablet ;anti-vitiligo effect of n-butanol part of Qubai tablet may be realized by promoting tyrosinase activity.